AMPK activation negatively regulates GDAP1, which influences metabolic processes and circadian gene expression in skeletal muscle

David G Lassiter, Rasmus J.O. Sjögren, Brendan M. Gabriel, Anna Krook, Juleen R. Zierath* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)
8 Downloads (Pure)

Abstract

Objective
We sought to identify AMPK-regulated genes via bioinformatic analysis of microarray data generated from skeletal muscle of animal models with genetically altered AMPK activity. We hypothesized that such genes would play a role in metabolism. Ganglioside-induced differentiation-associated protein 1 (GDAP1), a gene which plays a role in mitochondrial fission and peroxisomal function in neuronal cells but whose function in skeletal muscle is undescribed, was identified and further validated. AMPK activation reduced GDAP1 expression in skeletal muscle. GDAP1 expression was elevated in skeletal muscle from type 2 diabetic patients but decreased after acute exercise.

Methods
The metabolic impact of GDAP1 silencing was determined in primary skeletal muscle cells via siRNA-transfections. Confocal microscopy was used to visualize whether silencing GDAP1 impacted mitochondrial network morphology and membrane potential.

Results
GDAP1 silencing increased mitochondrial protein abundance, decreased palmitate oxidation, and decreased non-mitochondrial respiration. Mitochondrial morphology was unaltered by GDAP1 silencing. GDAP1 silencing and treatment of cells with AMPK agonists altered several genes in the core molecular clock machinery.

Conclusion
We describe a role for GDAP1 in regulating mitochondrial proteins, circadian genes, and metabolic flux in skeletal muscle. Collectively, our results implicate GDAP1 in the circadian control of metabolism.
Original languageEnglish
Pages (from-to)12-23
Number of pages12
JournalMolecular Metabolism
Volume16
Early online date25 Jul 2018
DOIs
Publication statusPublished - 1 Oct 2018

Bibliographical note

The Strategic Research Program in Diabetes at Karolinska Institutet (2009-1068), European Research Council Ideas Program (ICEBERG, ERC-2008-AdG23285), Swedish Research Council (2011-3550), Swedish Diabetes Foundation (DIA2012-082; DIA2012-047), Swedish Foundation for Strategic Research (SRL10-0027), Diabetes Wellness Sweden (2949/2014SW), Novo Nordisk Foundation and Stockholm County Council (NNF14OC0011493 and 20150326) supported this research. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Foundation. Håkan Karlsson and Petter Alm assisted with the initial collection and analysis of biopsies from our human participants. Nicolas Pillon and Jonathon Smith assisted with assay development and data collection, respectively and are affiliated with Department of Physiology and Pharmacology, Integrative Physiology, Karolinska Institutet, Stockholm, Sweden. Florian Salomons assisted with confocal microscopy and is affiliated with the Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.

Keywords

  • AMPK
  • Skeletal muscle
  • GDAP1
  • Diabetes
  • Circadian
  • Mitochondria

Fingerprint

Dive into the research topics of 'AMPK activation negatively regulates GDAP1, which influences metabolic processes and circadian gene expression in skeletal muscle'. Together they form a unique fingerprint.

Cite this